title: Effectiveness of pneumococcal conjugate vaccine in Greater Vancouver, Canada: 2004-2005.
abstract: Active, population-based surveillance for invasive pneumococcal infections in Greater Vancouver (population 473,000 children) demonstrated a rapid, substantial decrease in incidence rates for children 6-23 months old with routine infant vaccination. In the subpopulation with best case ascertainment disease rates for 6-23 month olds decreased 84.6% (92.5% for vaccine serotypes).
authors.affiliation: Vaccine Evaluation Center, BC Children's Hospital, Vancouver, B.C., Canada.
authors.forename: Gordean
authors.initials: G
authors.lastname: Bjornson
authors.forename: David W
authors.initials: DW
authors.lastname: Scheifele
authors.forename: Julie
authors.initials: J
authors.lastname: Bettinger
authors.forename: David M
authors.initials: DM
authors.lastname: Patrick
authors.forename: Larry
authors.initials: L
authors.lastname: Gustafson
authors.forename: Patricia
authors.initials: P
authors.lastname: Daly
authors.forename: Gregory J
authors.initials: GJ
authors.lastname: Tyrrell
mesh_terms: D000293:Adolescent; D002170:Canada / Q000453:epidemiology; D002648:Child; D002675:Child, Preschool; D000069443:Heptavalent Pneumococcal Conjugate Vaccine; D006801:Humans; D015994:Incidence; D007223:Infant; D007231:Infant, Newborn; D022401:Meningococcal Vaccines / Q000276:immunology*; D011008:Pneumococcal Infections / Q000453:epidemiology* / Q000517:prevention & control*; D022242:Pneumococcal Vaccines / Q000276:immunology*
chemical_list: D000069443:Heptavalent Pneumococcal Conjugate Vaccine; D022401:Meningococcal Vaccines; D022242:Pneumococcal Vaccines